Registry for patients after myocardial infarction treated with antiplatelet agents in Freiburg

• Conditions: I21; Acute myocardial infarction

• Registration Number: DRKS00003146
• Lead Sponsor: niversitätsklinikum Freiburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-06-27
• Results First Posted: 2013-10-31
• Study Completion: 2013-12-10
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 238

Inclusion Criteria

NSTE-ACS or STEMI, informed consent

Exclusion Criteria

none

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
cardiovascular death, myocardial infarction, stent-thrombosis, ischemic stroke evaluated in telephonic interviews after 12 and 36 months, respectively

Secondary Outcome Measures

Name	Time	Method
platelet aggregation assessed by impedance aggregometry at day 3-5 after myocardial infarction, adherence to physicians´ recommendation evaluated by telephonic interview after 12 months.